75N91018F00001↗

Name: 75N91018F00001: Novation From Cpic to UCSF Effect. 8/01/18--Surveillance, Epidemiology, and End Results (Seer) Program, Pop: 05/01/2018-04/30/2028
Creator: SpendQuery
License: https://www.usa.gov/government-works

NOVATION FROM CPIC TO UCSF EFFECT. 8/01/18--SURVEILLANCE, EPIDEMIOLOGY, AND END RESULTS (SEER) PROGRAM, POP: 05/01/2018-04/30/2028

Delivery Order · National Institutes of Health · to Regents of the University of California, San Francisco, the (UEI KMH5K9V7S518) · data as of 2026-10-21

Obligated to date$19.05M12 actions

Current value$41.54Mwith options exercised

Potential value$49.06Mif every option is used

Period2018-08-03 → 2027-04-30up to 2028-04-30 with options

Up for re-bid: ends 2027-04-30. Recompete brief →

What it is

Product or service: Health R&D Services; Health Care Services; Applied Research (PSC AN12)
Industry: Research and Development in the Physical, Engineering, and Life Sciences (Except Nanotechnology and Biotechnology) (NAICS 541715)
Contracting office: Nih Nci (75N910)
Competition: Full and open competition · 1 offer received
Pricing: Cost sharing
How it was bought: Multiple-award IDIQ · under 75N91018D00032
Solicitation: N01PC6500374
Where the work is: San Francisco, CA · district CA-11

Obligations by fiscal year

FY2023$4.75M

FY2024$5.31M

FY2025$4.39M

FY2026$4.61M

SpendQuery holds FY2023 on; earlier years are on USAspending.gov.

Subcontractors: where the money went next

No subawards reported for this award. Primes report subawards of $30,000 or more; many awards have none.

Every action

12 actions since 2023-03-21. Each is a modification or amendment with the money it added or took back.

Date	Modification	Kind	Amount	What the agency wrote
2026-08-28	P00019	Funding only	$858.0K	OBLIGATE FY 2026 FUNDS FOR AN INCREMENT FOR OPTION PD 8 IN ACCORDANCE WITH THE TERMS AND CONDITIONS OF AN INCREMENTALLY FUNDED COST REIMBURSEMENT, SEVERABLE SVCS CONTRACT; REVISED ARTS B.2, G.4.
2026-08-13	P00018	Funding only	-$817	DEOBLIGATE UNEXPENDED FY 2021 FUNDS FROM CLIN 303; 2) REDUCE AMOUNT OF CLIN 304, SUBSEQUENTLY REVISING ARTICLES B.2 AND B.4.
2026-04-24	P00017	Option exercised	$3.75M	SURVEILLANCE, EPIDEMIOLOGY, AND END RESULTS (SEER) PROGRAM
2025-04-30	P00016	Option exercised	$4.39M	SURVEILLANCE, EPIDEMIOLOGY, AND END RESULTS (SEER) PROGRAM
2025-03-03	P00015	Supplemental agreement (work within scope)	$0	SURVEILLANCE, EPIDEMIOLOGY, AND END RESULTS (SEER) PROGRAM
2024-09-27	P00014	Funding only	$1.07M	SURVEILLANCE, EPIDEMIOLOGY, AND END RESULTS (SEER) PROGRAM
2024-07-31	P00013	Supplemental agreement (work within scope)	-$67.5K	SURVEILLANCE, EPIDEMIOLOGY, AND END RESULTS (SEER) PROGRAM
2024-04-23	P00012	Option exercised	$4.06M	SURVEILLANCE, EPIDEMIOLOGY, AND END RESULTS (SEER) PROGRAM
2024-03-21	P00011	Funding only	$246.4K	SURVEILLANCE, EPIDEMIOLOGY, AND END RESULTS (SEER) PROGRAM, POP: 05/01/2018-04/30/2028
2023-08-18	P00010	Supplemental agreement (work within scope)	-$177.4K	SURVEILLANCE, EPIDEMIOLOGY, AND END RESULTS (SEER) PROGRAM, POP: 05/01/2018-04/30/2028
2023-04-25	P00009	Option exercised	$4.57M	SURVEILLANCE, EPIDEMIOLOGY, AND END RESULTS (SEER) PROGRAM, POP: 05/01/2018-04/30/2028
2023-03-21	P00008	Funding only	$352.7K	SURVEILLANCE, EPIDEMIOLOGY, AND END RESULTS (SEER) PROGRAM, POP: 05/01/2018-04/30/2028

Source: USAspending.gov prime award transactions and FSRS subaward reports, as loaded by SpendQuery (data as of 2026-10-21). Amounts are obligations (money committed), not outlays. The official record on USAspending.gov ↗

Putting the award page together from the records…